MBCI
Price:
$0.0001
Market Cap:
$7.03K
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.[Read more]
Industry
Solar
IPO Date
2007-12-05
Stock Exchange
PNK
Ticker
MBCI
According to MabCure, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.85% compared to the average of -6.60 of the last 4 quarters.
The mean historical PE Ratio of MabCure, Inc. over the last ten years is -423.91. The current -0.01 PE Ratio has changed -99.76% with respect to the historical average. Over the past ten years (40 quarters), MBCI's PE Ratio was at its highest in in the December 2011 quarter at -0.10. The PE Ratio was at its lowest in in the September 2007 quarter at -3679.29.
Average
-423.91
Median
-51.63
Minimum
-1953.61
Maximum
0
Discovering the peaks and valleys of MabCure, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -1953.61
Year | PE Ratio | Change |
---|---|---|
2011 | 0 | -100.00% |
2010 | -19.06 | -14.02% |
2009 | -22.17 | -72.66% |
2008 | -81.09 | -82.66% |
2007 | -467.56 | -76.07% |
The current PE Ratio of MabCure, Inc. (MBCI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.74
5-year avg
-117.97
10-year avg
-423.91
MabCure, Inc.’s PE Ratio is greater than Clear Blue Technologies International Inc. (-0.71), greater than GCL Technology Holdings Limited (-5.97), greater than Solar Alliance Energy Inc. (-121.06), less than SinglePoint Inc. (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
-0.71 | $1.87M | |
-5.97 | $3.70B | |
-121.06 | $7.34M | |
-0.00 | $9.52K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MabCure, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MabCure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MabCure, Inc.'s PE Ratio?
How is the PE Ratio calculated for MabCure, Inc. (MBCI)?
What is the highest PE Ratio for MabCure, Inc. (MBCI)?
What is the 3-year average PE Ratio for MabCure, Inc. (MBCI)?
What is the 5-year average PE Ratio for MabCure, Inc. (MBCI)?
How does the current PE Ratio for MabCure, Inc. (MBCI) compare to its historical average?